Research ArticleClinical Investigation
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients
Mathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica and Harun Ilhan
Journal of Nuclear Medicine May 2021, 62 (5) 669-674; DOI: https://doi.org/10.2967/jnumed.120.251017
Mathias Johannes Zacherl
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Franz Josef Gildehaus
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Lena Mittlmeier
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Guido Böning
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Astrid Gosewisch
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Vera Wenter
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Marcus Unterrainer
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
2Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
Nina Schmidt-Hegemann
2Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
Claus Belka
2Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
Alexander Kretschmer
3Department of Urology, University Hospital, LMU Munich, Munich, Germany; and
Jozefina Casuscelli
3Department of Urology, University Hospital, LMU Munich, Munich, Germany; and
Christian G. Stief
3Department of Urology, University Hospital, LMU Munich, Munich, Germany; and
Marcus Unterrainer
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
4Department of Radiology, University Hospital, LMU Munich, Munich, Germany
Peter Bartenstein
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Andrei Todica
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
Harun Ilhan
1Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 5
May 10, 2021
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients
Mathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, Harun Ilhan
Journal of Nuclear Medicine May 2021, 62 (5) 669-674; DOI: 10.2967/jnumed.120.251017
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients
Mathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, Harun Ilhan
Journal of Nuclear Medicine May 2021, 62 (5) 669-674; DOI: 10.2967/jnumed.120.251017
Jump to section
Related Articles
Cited By...
- No citing articles found.